The effect of primaquine on lecithin metabolism in human erythrocytes

The effect of primaquine on lecithin metabolism in human erythrocytes

594 BBA SHORTCOMMUNICATIONS 53102 The effect of primaquine on lecithin metabolism in human erythrocytes Human erythrocytes exposed to prelytic conce...

309KB Sizes 2 Downloads 93 Views

594 BBA

SHORTCOMMUNICATIONS 53102

The effect of primaquine on lecithin metabolism in human erythrocytes Human erythrocytes exposed to prelytic concentrations of primaquine in vitro manifest increased leakage of K+ and hypersensitivity to osmotic lysisl. Both of these responses

are considered

to indicate

The recent demonstration

an impaired

integrity

of an active phospholipid

of the red cell membrane.

metabolism

the mature human red ce112m4suggested that these functional brane effected metabolism.

by primaquine

might

be accompanied

in the membrane

alterations

by changes

of

of the mem-

in phospholipid

Venous blood was obtained from clinically normal adult males. The red cells were isolated by diluting the freshly drawn blood with an equal volume of a 3% solution

of bovine

fibrinogen-citrate

in isotonic

NaCl. After

complete

mixing,

the

blood cells were allowed to sediment at room temperature and the buffy coat and top 10% of the red cell layer were removed. The red cell mass was then washed 3 times with phosphate-buffered,

isotonic

NaCl (pH 7.4), at o-4”, the top 3-5 o/0of the

red cell layer being discarded each time. The red cells were finally suspended in ice cold calcium-free Krebs-Ringer phosphate solution (pH 7.4), to a hematocrit of 75 o/o and used immediately.

As determined

by cell counts,

white cell contamination

of the

red cell mass prepared by this method ranged from o-2 white cells per IOOOOO red cells. This was confirmed by the rarity of white cells as well as the virtual absence of platelets

identified

in stained blood films.

Red cell membranes were prepared by a modification of the method of DODGE, MITCHELL AND HANAHAN~. Hemolysis was accomplished by placing the red cells in IO vol. of an aqueous

solution

of IO-* M EDTA

and 1.7 . IO-~ M Tris (pH 7.4), at

o-4” for IO min. The membranes were sedimented by centrifuging at 54 500 x g for 15 min and then washed 3 times with the EDTA-Tris solution and once with calciumfree Krebs-Ringer

phosphate

(pH 7.4).

Metabolic reactions were carried out in a shaking water bath at 37’ using 25 ml erlenmeyer flasks with air as the gaseous phase. The reactions were terminated by initiating the preparation of membranes when intact red cells were used or starting the lipid extraction when membranes were used. Extraction, chromatographic separation, and preparation of phospholipids for liquid scintillation spectroscopy were done as previously

describeds.

[I-l%]Palmitic acid, [I-%]linoleic acid, [r-14C]palmityl-CoA and palmityl-CoA were prepared or obtained as described previously 8. Lecithin containing [I-X]palmitic acid was prepared by incubating red cell membranes withlysolecithinand[r-14C]palmityl-CoA followed by extraction and chromatographic separation of the lecithin. Lysolecithin was prepared from egg lecithin by the method of LANG AND PENNY'. Bovine fibrinogen-citrate was obtained from Armour Pharmaceutical Co., Kankakee, Ill. Primaquine phosphate was a gift from Dr. R. 0. CLINTON, Sterling-Winthrop Research Institute, Rensselaer, New York. The rate of [I-%]linoleic acid incorporation into lecithin of intact red cells was markedly enhanced in the presence of primaquine. This stimulation was observed for periods as long as 90 min and was proportional to the primaquine concentration (Figs, I and 2). Incorporation of [I-‘4C]palmitic acid into lecithin was less rapid than Biochim.

Biophys.

Acta,

125 (1966)

594-597

505

SHORT COMMUNICATIONS

that of linoleic acid, but the degree of stimulation effected by the primaquine was similar. The accelerated formation of [Xllecithin in the red cells in the presence of primaquine predicated a concomitant increase in the availability of phosphoglyceride

/

Fig. I. The effect in the presence of min per mpmole), Ringer phosphate incubation was at

d

I

1

I

2

Primaqui ne

of duration of incubation on [W]lecithin formation by intact human red cells primaquine. The system contained 80 mpmoles of linoleic acid (1600 counts/ 1.35 ml of red cells suspended to a 75 yO hematocrit in calcium-free Krebsbuffer (pH 7.4). and IO pmolcs of primaquine. Final volume was 2.0 ml and 37”.

I

I

6 4 Primoauine fpmoles)

I

I

8

to’

Fig. a. The effect of primaquine on [f*C]lecithin formation by intact human red cells. The system contained 80 mpmoles of linoleic acid (rdoo counts/min per mpmole), 1.35 ml of red cells suspended to a 75 yO hematocrit in calcium-free Krebs-Ringer phosphate buffer (pH 7.4), and primaquine as indicated. Final volume was 2.0 ml and incubation was at 37O for go min.

acceptor. Several investigators, however, have been unable to demonstrate phospholipase A activity in the red cell 2-4, and an attempt to detect a primaquine-activated lecithinase in the red cell was likewise unsuccessful (Table I). Since de BOVOsynthesis of lecithin in the red cell appears to be insignificant s, and, in these experiments, no exogenous acceptor was added to the reaction system and the red cells were thoroughly washed free of serum, endogenous lysophosphoglyceride appears to have served as Biochina.Biofihys.

Acta,

125 (1966) 594-597

SHORT COMMUNICATIONS

596 TABLE

I

PHOSPHOLIPASEA ACTIVITY IN THE RED CELL The system contained 4 m,mnoles of [%jlecithin (2250 counts/min per mpmole), and 1.35 ml of intact red cells suspended in calcium-free Krebs-Ringer phosphate buffer (pH 7.4), (75 o/0 hematocrit). In addition, tubes z and 4 contained IO Llmoles of primaquine and tubes 3 and 4, IOO mpmoles of non-radioactive palmitic acid. Final volume was 2.0 ml and incubation was at 37’ for 60 min. Pgimaquine

Tube

I

[W]Lecithin (counts~min)

14C-labeled fatty acid

(c0u&/min,l

4279

-

2

+

3 4

+

0

4558 4699 4458

0 0 0

the major substrate

for acylation.

mation

an otherwise

by exposing

to the activated

fatty

Thus, primaquine inaccessable

of lysolecithin

[14C]lecithin forin the red cell

acids.

Phospholipids and phospholipid metabolism Although primaquine consistently

membrane2y6. incorporation

may accelerate

reservoir

into lecithin

of intact

in the red cell are confined to the accelerated long chain fatty acid

red cells, incorporation

of long chain fatty

acid

into lecithin of membranes prepared from red cells by osmotic lysis was, paradoxically, inhibited (Table II). This inhibition did not appear to be due to removal of a required TABLE

II

INFLUENCEOF RED CELL INTEGRITY ON PRIMAQUINESTIMULATED[~X]LECITHIN

FORMATION

The system contained 25 mpmoles of [‘%]palmityl-CoA (2500 counts/min per mpmole), 10 /,&moles of primaquine as indicated, and 1.35 ml of intact red cells suspended in calcium-free Krebs-Ringer phosphate buffer, (pH 7.4), to a 750/u hematocrit, or the equivalent of red cells hemolyzed by repeated freezing and thawing, or red cell membranes (1.5 mg protein) suspended in the buffer to a 20 y0 hematocrit with or without I ml of the “supernatant” prepared by removing the membranes of hemolyzed red cells. Final volume was 2.0 ml and incubation was at 37’ for 30 min. Primaquine (counts/min)

Erythroc_vtes

y; Change

+ ~Intact Hemolyzed Membranes Membranes

+ “Supernatant”

5’6 7676 9900 8159

970 50’0 3152 3636

$88 -34 -68 -55

cofactor during membrane preparation, since lecithin formation was also by primaquine in hemolysates from which the membranes had not been These observations suggest that a molecular rearrangement occurs during so that primaquine has an inhibitory effect on the lysolecithin acylating In erythrocytes exposed to primaquine in vitro and in viva, hydrogen

depressed separated. hemolysis enzymes. peroxide is

generated at increased ratesO. The formation of the peroxide requires the presence of ferro-hemoglobin, and the peroxide generated is rapidly detoxified via the glutathione peroxidase pathway which requires the presence of glucose to maintain adequate levels of reduced glutathione. In order to determine whether the effect of primaquine on lecithin metabolism was a consequence of hydrogen peroxide accumulation, 3 types Biochim. Biophys.

Acta, 125 (1966) 594-597

597

SHORT COMMUNICATIONS

of experiments were carried out: (I) the potential formation of peroxide in red cells incubated with primaquine was blocked by prior conversion of the hemoglobin to methemoglobin; (2)the accumulation of peroxide was prevented by incubating the red cells with primaquine in the presence of glucose; and (3) hydrogen peroxide rather than primaquine was added directly to the red cells by a gaseous diffusion technique. In the first 2 types of experiments, the effect of primaquine on [Xllecithin formation was unchanged despite the fact that peroxide could not be generated in the presence of methemoglobin and despite the fact that if peroxide were formed it would be rapidly eliminated in the presence of glucose. Lastly, no evidence was found that peroxide itself mimics the effect of primaquine on phospholipid metabolism. Thus, the mechanism whereby primaquine affects lecithin metabolism in the red cell does not appear to be directly related to hydrogen peroxide and oxy-redox reactions of these cells. In recent years, a number of investigators have attempted to relate the flux of Na+ and K+ in the red cell to its phospholipid metabolismlO. The observation that primaquine, an agent known to cause an accelerated loss of K+ and gain of Na+ in the red cell, has an effect on erythrocyte phospholipid metabolism lends support to this postulated association. The mechanism whereby primaquine produces this dual effect on the red cell remains to be elucidated. This investigation was supported by Grant HE 10090 from the National Heart Institute, National Institutes of Health, United States Public Health Service, Grant 64-G-116 from the American Heart Association, and Grant GB 1416 from the National Science Foundation. Departments of Pathology, amd Physiology Duke University

and Pharmacology,

BENJAMIN

Medical Center,

PAUL

WITTELS

HOCHSTEIN

Durham, N. C. (U.S.A.) I R. WEED, J. EBER AND A. ROTHSTEIN, J. C&n. Invest., 40 (1961) 130. 2 M. M. OLIVEIRA AND M. VAUGHAN, J. Lipid Res., 5 (1964)156. 3 A. F. ROBERTSON AND W. E. M. LANDS, J. Lipid Res., 5 (1964) 88. 4 E. MULDER AND L. L. M. VAN DEENEN, Biochim. Biophys. Acta, 106 (1965)

106. 5 J. T. DODGE, C. MITCHELL AND D. J. HANAHAN, Arch. Biochem. Biophys., IOO (1963) 119. 6 B. WITTELS AND R. BRESSLER, J. Clin. Invest., 44 (1965) 1639. 7 C. LONG AND I. F. PENNY, Biochem. J., 65 (1957) 382. 8 E. MULDER AND L. L. M. VAN DEENEN, Biochim. Biophys. Acta, 106 (1965) 348. g G. COHEN AND P. HOCHSTEIN, Biochemistry, 3 (1964) 895. IO L. L. M. VAN DEENEN, in R. T. HOLMAN, Pryress in the Chemistry of Fats and other Lipids, Vol.8,Part I, Pergamon Press, New York, 1965.

Received June 23rd, 1966 Biochim. BBA

Biophys.

Acta,

125 (1966) 594-597

53106

On the positional specificity of pancreatic lipase A number of experiments performed in several laboratories have demonstrated that pancreatic lipase (EC 3.1.1.3) displays a very strong specificity towards the exB&him.

Biophys.

Acta,

125 (1966) 597-600